Myles David C.

CIK 00018312161 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001831216

Recent Transactions

23 trades

Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2024-12-11$9.39/sh−300→ 598,333 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2024-12-11$8.66/sh−13,314→ 598,633 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2024-12-10$9.38/sh−12,452→ 611,947 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2024-12-09+48,750→ 624,399 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2024-02-01+195,000→ 195,000 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-22$13.89/sh−6,653→ 574,099 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-21$14.87/sh−6,776→ 580,952 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-21$15.32/sh−200→ 580,752 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-20+26,250→ 587,728 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-08$17.61/sh−200→ 561,270 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-03$17.51/sh−541→ 561,470 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-02$15.36/sh−3,332→ 562,011 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-11-01$15.02/sh−6,668→ 565,343 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2023-09-19$12.67/sh−20,000→ 572,011 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2023-02-01+150,000→ 150,000 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2022-02-01+118,750→ 118,750 total
Sale
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2021-12-10$10.30/sh−10,000→ 582,901 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Series A Convertible Preferred Stock
2020-11-23−154,846→ 0 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2020-11-23+12,831→ 12,831 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2020-11-23+154,846→ 154,846 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Series A Convertible Preferred Stock
2020-11-23−12,831→ 0 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2020-11-18+179,340→ 179,340 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2020-06-15+143,472→ 591,821 total

Companies

Olema Pharmaceuticals, Inc.
Chief Development Officer
$OLMA

Recent Filings

Address

C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR

SAN FRANCISCO, CA, 94107

View on SEC.gov